Exchange: NASDAQ·Updated 07:04 PM EDT
OMER logo

OMER Omeros Corp

$19.03
$0.16
(0.84%)
Today
Closed $18.95
$0.08
(0.42%)
After Hours
Reported EarningsAug 12
Mkt Cap$1.38B
Vol892,191.00

About OMER

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
26

Bearish Sentiment

How do you feel about OMER?

Advertisement|Remove ads.